Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DIVIDEND DETAILS
Dividend Details      
Amrutanjan Health Care Ltd.
Dividend DateRecord DateDividend %Dividend AmountInterim / Final / Dividend
06 Feb 202607 Feb 20261001Interim
18 Nov 202518 Nov 20251001Interim
16 Sep 202516 Sep 20252602.6Final
18 Feb 202518 Feb 20251001Interim
22 Nov 202422 Nov 20241001Interim
13 Sep 202417 Sep 20242602.6Final
20 Feb 202420 Feb 20241001Interim
23 Nov 202323 Nov 20231001Interim
14 Sep 202314 Sep 20232602.6Final
24 Feb 202324 Feb 20231001Interim
14 Nov 202215 Nov 20221001Interim
14 Sep 202216 Sep 20222602.6Final
18 Feb 202221 Feb 20221001Interim
16 Nov 202117 Nov 20211001Interim
15 Sep 202116 Sep 20212602.6Final
(Page 1 of 1)
Previous || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.